Evaluation of Nitric Oxide Production by Leishmania Infantum-infected Dog Macrophages

References

• Buchmüller Y., Mauël J. Studies on the mechanism of macrophage activation. II Parasite destruction in macrophages activated by supernatants from Concanavalin A-stimulated lymphocytes. J. Exp. Med. 1979; 150: 359
   PubMed Web of Science ®Google Scholar
• Brandonisio O., Carelli G., Ceci L., Consenti B., Fasanella A., Puccini V. Canine leishmaniasis in the Gargano Promontory (Apulia, South Italy). Eur. J. Epidemiol. 1992; 8: 273
   PubMed Web of Science ®Google Scholar
• Gramiccia M., Gradoni L., Angelici M. C. NATO-ASI monograph on leishmaniasis, D. J. Hart. Plenum Press, New York 1989; 21
   Google Scholar
• Gramiccia M., Gradoni L., Troiani M. HIV-Leishmania co-infection in Italy. Isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients. Trans. R. Soc. Trop. Med. Hyg. 1992; 86: 161
   PubMed Web of Science ®Google Scholar
• Murray H. W. Susceptibility of Leishmania to oxygen intermediates killing by normal macrophages. J. Exp. Med. 1981; 153: 1302
   PubMed Web of Science ®Google Scholar
• Brandonisio O., Panunzio M., Faliero S. M., Ceci L., Fasanella A., Puccini V. Evaluation of polymorphonuclear cell and monocyte functions in Leishmania infantum-infected dogs, Vet. Immunol. Immunopathol. 1996; 53: 95
   Google Scholar
• Green S. J., Meltzer M. S., Hibbs J. B., Nacy C. A. Activated macrophages destroy Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 1990; 144: 278
   PubMed Web of Science ®Google Scholar
• Liew F. Y., Yun L., Millot S. TNFα synergizes with IFNγ in mediating killing of Leishmania major throught the indution of nitric oxide. J. Immunol. 1990; 145: 4306
   PubMed Web of Science ®Google Scholar
• Mauel J., Ransijn A., Buchmuller-Rouiller Y. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivates. J. Leuk. Biol. 1991; 49: 73
   PubMed Web of Science ®Google Scholar
• Wei X Q., Charles I. G., Smith A., Ure J., Feng C. J., Huang P. P., Xu D. M., Muller W., Moncada S., Liew F. Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995; 375: 408
   PubMed Web of Science ®Google Scholar
• Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 1991; 43: 109
   PubMed Web of Science ®Google Scholar
• Mauel J., Buchmuller-Rouiller Y. Effect of lipopolysaccharide on intracellular killing of Leishmania enriettii and correlation with macrophage oxidative metabolism. Eur. J. Immunol. 1987; 17: 203
   PubMed Web of Science ®Google Scholar
• Ding A. H., Nathan C. F., Stuher D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 1988; 141: 2407
   PubMed Web of Science ®Google Scholar
• Green S. J., Scheller L. F., Marietta M. A., Seguin M. C., Klotz F. W., Slayter M., Nelson B. J., Nacy C. A. Nitric oxide: cytokine regulation of nitric oxide in host resistance to intracellular pathogens, Immunol. Letters 1994; 43: 87
   Google Scholar
• Pinelli E., Rutten V., Ruitenberg J. Protective immune responses in canine visceral leishmaniosis. VII European Multicolloquium of Parasitology, ParmaItaly, 2–6 September, 1996, Abstracts
   Google Scholar
• Valdoukis I., Drapier J. C., Nussler A. K., Tselentis Y., Da Silva O. A., Gentilini M., Mossalayi D. M., Monjour L., Dugas B. Canine visceral leishmaniasis: successful chemotherapy induces macrophages antileishmanial activity via the L-arginine nitric oxide pathway, Antimicrob. Agents Chemother. 1996; 40: 253
   PubMed Web of Science ®Google Scholar
• Panaro M. A., Lisi S., Fasanella A., Scalinci V., Settanni M. P., Brandonisio O. Evaluation of nitric oxide production by Leishmania infantum- infected dog and human monocytes. VII European Multicolloquium of Parasitology, ParmaItaly, 2–6 September, 1996, Abstracts
   Google Scholar
• Evans D. A. Methods of Cultivating Parasites in Vitro, A. E. R. Taylor, J. R. Baker. Academic Press, London 1978; 55
   Google Scholar
• Pantazis C. G., Kniker W. T. Assessment of blood leukocyte microbial killing by using a new fluoro-crome microassay. J. Reticuloendothel. Soc. 1979; 26: 155
   PubMedGoogle Scholar
• Corradin S. B., Mauël J. Phagocytosis of Leishmania enhances macrophage activation by IFN-y and lipopolysaccharides. J. Immunol. 1991; 146: 279
   PubMed Web of Science ®Google Scholar
• Pietraforte D., Tritarelli E., Testa U., Minetti M. Gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J. Leuk. Biol. 1994; 55: 175
   PubMed Web of Science ®Google Scholar
• Chartrain N. A., Geller D. A., Koty P. P., Sitrin N. F., Nussler A. K., Hoffman E. P., Billiar T. R., Hutchinson N. I., Mudgett J. S. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. 1994; 269: 6765
   PubMed Web of Science ®Google Scholar
• Kroncke K. D., Fehsel K., Alsdorff K., Kolb-Bachofen V. Expression of inducible NO-synthase in human monocytes. Immunobiol. 1994; 191: 267
   Google Scholar
• Reiling N., Ulmer A. J., Duchrow M., Ernst M., Flad H. D., Andhayschidt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 1941; 24: 1994
   Google Scholar
• Weinberg J. B., Misukonis M. A., Shami P. J., Mason S. N., Sauls D. L., Dittman W. A., Wood E. R., Smith G. K., McDonald B., Bachus K. E., Haney A. F., Granger D. L. Human mononuclear phagocyte inducible nitric oxide synthase (iNOs): analysis of iNOs mRNA, iNOs protein, biopterin, and nitric oxide production by blood monocytes and peripheral macrophages. Blood 1995; 86: 1184
   PubMed Web of Science ®Google Scholar
• Pinelli E., Gonzalo R. M., Boog C. J. P., Rutten V. P. M. G., Gebhard D., del Real G., Ruitenberg E. J. Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner. Eur. J. Immunol. 1995; 25: 1594
   PubMed Web of Science ®Google Scholar
• Adler H., Freeh B., Thony M., Pfister H., Peterhans E., Jungi T. W. Inducible nitric oxide synthase in cattle: differential cytokine regulation of nitric oxide synthase in bovine and murine macrophages. J. Immunol. 1995; 154: 4710
   PubMed Web of Science ®Google Scholar
• Adler H., Adler B., Peveri P., Werner E. R., Wachter H., Peterhans E., Jungi T. W. Differential regulation of inducible nitric oxide synthase production in bovine and caprine macrophages. J. Infect. Dis. 1996; 173: 971
   PubMed Web of Science ®Google Scholar
• Zhao B., Collins M. T., Czuprynski C. J. Effects of gamma interferon and nitric oxide on the interaction of Mycobacterium avium subsp. paratubercolusis with bovine monocytes. Infect. Immun. 1997; 65: 1761
   PubMed Web of Science ®Google Scholar
• Geller D. A., Lowenstein C. J., Shapiro R. A., Nussler A. K., Silvio M. D., Wang S. C., Nakayama G. K., Simmons R. L., Snyder S. H., Billiar T. R. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc: Natl. Acad. Sci. USA 1993; 90: 3491
   PubMed Web of Science ®Google Scholar
• Alonso A., Carvalho J., Alonsotorre S. R., Nunez L., Bosca L., Crespo M. S. Nitric oxide synthesis in rat peritoneal macrophages is induced by IgE/DNP complexes and cyclic AMP analogues - Evidence in favour of a common signaling mechanism. J. Immunol. 1995; 154: 6475
   PubMed Web of Science ®Google Scholar
• Valdoukis I., Issaly F., Fourcade C., Paul-Eugene N., Arock M., Kolb J. P., Alves da Silva O., Monjour L., Poinsot H., Tselentis Y., Dugas B., Debré P., Mossalayi M. D. CD23 and IgE expression during the human immune response to cutaneous leishmaniasis: possible role in monocyte activation. Res. Immunol. 1994; 145: 17
   PubMedGoogle Scholar
• De Maria R., Cifone M. G., Trotta R., Rippo M. R., Festucia C., Santoni A., Testi R. Triggering of human monocyte activation through CD69, a member of the NKC family of signal transducing receptors. J. Exp. Med. 1994; 180: 1999
   PubMed Web of Science ®Google Scholar
• Bukrinsky M. I., Nottet H. S. L. M., Schmidtmayerova N., Dubrovsky L., Mullins M. E., Lipton S. A., Gendelman H. E. Regulation of nitric oxide synthase activity in HIV-1-infected monocytes: implications for HIV-associated neurological disease. J. Exp. Med. 1995; 181: 735
   PubMed Web of Science ®Google Scholar
• Norris K. A., Schrimpf J. E., Flynn J. L., Morris S. M., Jr. Enhancement of macrophage microbicidal activity: supplemental arginine and citrulline augment nitric oxide production in murine peritoneal macrophages and promote intracellular killing of Trypanosoma cnizi. Infect Immun. 1995; 63: 2793
   PubMed Web of Science ®Google Scholar
• Azzara A., Carulli G., Sbrana S., Rizzuti-Gullaci A., Minnucci S., Natale M., Ambrogi F. Effects of lysine-arginine association on immune functions in patients with recurrent infections. Drugs Exptl. Clin. Res. 1995; 21: 71
   PubMedGoogle Scholar
• Porsti I., Paakkari L. Nitric oxide-based possibilities for pharmacotherapy. Annls Med 1995; 27: 407
   PubMed Web of Science ®Google Scholar
• Mauel J., Ransijn A., Corradin S. B., Buchmuller-Rouiller Y. Effect of PGE2 and of agents that raise cAMP levels on macrophage activation induced by IFN-γ and TNF-α. J. Leukoc. Biol 1995; 58: 217
   PubMed Web of Science ®Google Scholar